These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37269419)

  • 1. Factors influencing wait-and-watch management in mild primary chronic subdural hematoma: a retrospective case-control study.
    Zhang X; Sha Z; Gao C; Yuan J; He L; Huang J; Jiang R
    Acta Neurol Belg; 2023 Dec; 123(6):2277-2286. PubMed ID: 37269419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Atorvastatin as a Monotherapy for Chronic Subdural Hematoma: A Retrospective Multifactor Analysis.
    Zhang X; Wang D; Tian Y; Wei H; Liu X; Xiang T; Fan Y; Gao C; Huang J; Sha Z; Quan W; Zhang J; Jiang R
    Front Aging Neurosci; 2021; 13():726592. PubMed ID: 34539386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factor Analysis of the Conservative Treatment in Chronic Subdural Hematomas: A Substudy of the ATOCH Trial.
    Wang D; Tian Y; Wei H; Gao C; Fan Y; Yang G; Quan W; Huang J; Yue S; Zhang J; Jiang R
    Adv Ther; 2022 Apr; 39(4):1630-1641. PubMed ID: 35133631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with success of conservative therapy in chronic subdural hematoma: a single-center retrospective analysis.
    Foppen M; Lodewijkx R; Bandral HV; Yah K; Slot KM; Vandertop W; Verbaan D
    J Neurol; 2024 Jun; 271(6):3586-3594. PubMed ID: 38554149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Affecting Outcome in Treatment of Chronic Subdural Hematoma in ICU Patients: Impact of Anticoagulation.
    Szczygielski J; Gund SM; Schwerdtfeger K; Steudel WI; Oertel J
    World Neurosurg; 2016 Aug; 92():426-433. PubMed ID: 27241090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Outcome of Medical Management of Chronic Subdural Hematoma with Tranexamic Acid - A Prospective Observational Study.
    Kutty RK; Leela SK; Sreemathyamma SB; Sivanandapanicker JL; Asher P; Peethambaran A; Prabhakar RB
    J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105273. PubMed ID: 33066896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drain type after burr-hole drainage of chronic subdural hematoma in geriatric patients: a subanalysis of the cSDH-Drain randomized controlled trial.
    Greuter L; Lutz K; Fandino J; Mariani L; Guzman R; Soleman J
    Neurosurg Focus; 2020 Oct; 49(4):E6. PubMed ID: 33002868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom.
    Brennan PM; Kolias AG; Joannides AJ; Shapey J; Marcus HJ; Gregson BA; Grover PJ; Hutchinson PJ; Coulter IC;
    J Neurosurg; 2017 Oct; 127(4):732-739. PubMed ID: 27834599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of atorvastatin for chronic subdural haematoma: a retrospective cohort comparison study
    Chan DY; Chan DT; Sun TF; Ng SC; Wong GK; Poon WS
    Br J Neurosurg; 2017 Feb; 31(1):72-77. PubMed ID: 27881024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral chronic subdural hematoma: what is the clinical significance?
    Huang YH; Yang KY; Lee TC; Liao CC
    Int J Surg; 2013; 11(7):544-8. PubMed ID: 23707986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors of hospital mortality in chronic subdural hematoma: A retrospective analysis of 1117 patients, a single institute experience.
    Wang S; Ma Y; Zhao X; Yang C; Gu J; Weng W; Hui J; Mao Q; Gao G; Feng J
    J Clin Neurosci; 2019 Sep; 67():46-51. PubMed ID: 31213382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and validation of a CT-based prediction model for the good dissolution of mild chronic subdural hematoma with atorvastatin treatment.
    Zhang X; Sha Z; Feng D; Wu C; Tian Y; Wang D; Wang J; Jiang R
    Neuroradiology; 2024 Jul; 66(7):1113-1122. PubMed ID: 38587561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivation of a Clinical Score for Prediction of Recurrence Following Evacuation of Chronic Subdural Hematoma: A Retrospective Cohort Study at a National Referral Centre.
    Amoo M; O'Cearbhaill RM; McHugh P; Henry J; O'Byrne K; Ben Husien M; Javadpour M
    World Neurosurg; 2021 Oct; 154():e743-e753. PubMed ID: 34343685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Prognosis of Patients with Chronic Subdural Hematoma: A New Scoring System.
    Kwon CS; Al-Awar O; Richards O; Izu A; Lengvenis G
    World Neurosurg; 2018 Jan; 109():e707-e714. PubMed ID: 29061462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ATorvastatin On Chronic subdural Hematoma (ATOCH): a study protocol for a randomized controlled trial.
    Jiang R; Wang D; Poon WS; Lu YC; Li XG; Zhao SG; Wang RZ; You C; Yuan XR; Zhang JM; Feng H; Fei Z; Yu XG; Zhao YL; Hu J; Kang DZ; Yu RT; Gao GD; Zhu XD; Sun T; Hao JH; Liu XZ; Su N; Yue SY; Zhang JN
    Trials; 2015 Nov; 16():528. PubMed ID: 26581842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence in 787 Patients with Chronic Subdural Hematoma: Retrospective Cohort Investigation of Associated Factors Including Direct Oral Anticoagulant Use.
    Motoie R; Karashima S; Otsuji R; Ren N; Nagaoka S; Maeda K; Ikai Y; Uno J; Gi H
    World Neurosurg; 2018 Oct; 118():e87-e91. PubMed ID: 29945004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Atorvastatin for Chronic Subdural Hematoma in Chinese Patients: A Randomized ClinicalTrial.
    Jiang R; Zhao S; Wang R; Feng H; Zhang J; Li X; Mao Y; Yuan X; Fei Z; Zhao Y; Yu X; Poon WS; Zhu X; Liu N; Kang D; Sun T; Jiao B; Liu X; Yu R; Zhang J; Gao G; Hao J; Su N; Yin G; Zhu X; Lu Y; Wei J; Hu J; Hu R; Li J; Wang D; Wei H; Tian Y; Lei P; Dong JF; Zhang J
    JAMA Neurol; 2018 Nov; 75(11):1338-1346. PubMed ID: 30073290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of atorvastatin on chronic subdural hematoma: a preliminary report from three medical centers.
    Wang D; Li T; Tian Y; Wang S; Jin C; Wei H; Quan W; Wang J; Chen J; Dong J; Jiang R; Zhang J
    J Neurol Sci; 2014 Jan; 336(1-2):237-42. PubMed ID: 24269089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The conservative and pharmacological management of chronic subdural haematoma.
    Soleman J; Nocera F; Mariani L
    Swiss Med Wkly; 2017; 147():w14398. PubMed ID: 28102879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for the development of chronic subdural hematoma in patients with subdural hygroma.
    Fan G; Ding J; Wang H; Wang Y; Liu Y; Wang C; Li Z
    Br J Neurosurg; 2021 Feb; 35(1):1-6. PubMed ID: 31992088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.